ClinicalTrials.Veeva

Menu

Radiation-associated Carotid Artery Disease in Patients With Nasopharyngeal Carcinoma

Fudan University logo

Fudan University

Status

Unknown

Conditions

Nasopharyngeal Carcinoma
Carotid Artery Diseases

Treatments

Other: Medical history of cardiovascular risk factors and cardiovascular diseases
Diagnostic Test: Montreal Cognitive Assessment
Diagnostic Test: Carotid Color Flow Duplex Testing
Diagnostic Test: Detection and measurement of carotid plaques
Diagnostic Test: Measurement of intima media thickness of carotid artery

Study type

Observational

Funder types

Other

Identifiers

NCT03568032
NPC-CAROTID-01

Details and patient eligibility

About

Radiation-associated carotid vasculopathy is a common late sequelae in patients with head and neck cancer, which correlates with the incidence of stroke. Currently, little is known about the incidence of radiation-associated carotid vasculopahty in the context of intensity-modulated radiation therapy (IMRT).

The aim of this study is to determine whether IMRT will increase the incidence of carotid vasculopathy in patients with nasopharyngeal carcinoma (NPC).

Enrollment

248 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • signed inform consent
  • age more than 18 years old
  • ECOG 0-2
  • pathologic diagnosed, non-metastatic NPC
  • either untreated or treated by definitive IMRT 3 years ago
  • did not receive radiation to the head and neck region prior to the diagnosis of NPC
  • if the patient received definitive IMRT 3 years ago because of NPC, he or she did not receive a second course of radiation due to local relapse
  • no prior surgery of head and neck

Exclusion criteria

  • prior history of cardiovascular disease before the diagnosis of NPC
  • prior radiation to head and neck before the diagnosis of NPC
  • prior surgery of head and neck
  • pregnant or lactating women

Trial design

248 participants in 2 patient groups

the post-radiation group
Description:
patients diagnosed as non-metastatic nasopharyngeal carcinoma who received definitive IMRT more than 3 years ago
Treatment:
Diagnostic Test: Montreal Cognitive Assessment
Diagnostic Test: Carotid Color Flow Duplex Testing
Other: Medical history of cardiovascular risk factors and cardiovascular diseases
Diagnostic Test: Detection and measurement of carotid plaques
Diagnostic Test: Measurement of intima media thickness of carotid artery
the pre-radiation group
Description:
untreated patients diagnosed as non-metastatic nasopharyngeal carcinoma
Treatment:
Diagnostic Test: Montreal Cognitive Assessment
Diagnostic Test: Carotid Color Flow Duplex Testing
Other: Medical history of cardiovascular risk factors and cardiovascular diseases
Diagnostic Test: Detection and measurement of carotid plaques
Diagnostic Test: Measurement of intima media thickness of carotid artery

Trial contacts and locations

1

Loading...

Central trial contact

Xiaomin Ou, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems